COPENHAGEN, Denmark, April 12, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the fourth quarter and year ended December 31, 2015. Net loss for the fourth quarter and year ended December 31, 2015 was $9.6 million and $37.0 million, respectively. Loss per share for the fourth quarter and year ended December 31, 2015 was $0.20 and $0.79, respectively. On a non-GAAP basis, after removing the effect of non-cash income and expense items, our fourth quarter and year ended 2015 net loss would have been $8.4 million and $35.4 million, or $0.18 and $0.76 per share, respectively. As of December 31, 2015, the Company had $176.7 million in cash, cash equivalents and marketable securities, with no debt outstanding.
